Gentamicin C1a pentaacetate
CAS: 26098-04-4
Rif. 3D-AG16458
| 1mg | 490,00 € | ||
| 2mg | 745,00 € | ||
| 5mg | 1.454,00 € | ||
| 10mg | 2.556,00 € |
Informazioni sul prodotto
- O-3-Deoxy-4-C-methyl-3-(methylamino)-b-L-arabinopyranosyl-(1-6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-a-D-erythro-hexopyranosyl-(1-4)]-2 -deoxy-D-streptamine pentaacetate saltGentamicin D acetateGentamycin C1a acetate
- <span class="text-smallcaps">D</smallcap>-Streptamine, O-3-deoxy-4-C-methyl-3-(methylamino)-β-<smallcap>L</smallcap>-arabinopyranosyl-(1→6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-α-<smallcap>D</span>-erythro-hexopyranosyl-(1→4)]-2-deoxy-
- Geneticin C<sub>1a</sub>
- Gentamicin C1a
- Gentamicin C<sub>1a</sub>
- Gentamicin C<sub>3</sub>
- Gentamycin C<sub>1a</sub>
- O-3-Deoxy-4-C-methyl-3-(methylamino)-β-<span class="text-smallcaps">L</smallcap>-arabinopyranosyl-(1→6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-α-<smallcap>D</smallcap>-erythro-hexopyranosyl-(1→4)]-2-deoxy-<smallcap>D</span>-streptamine
Gentamicin C1a pentaacetate is a prodrug that is converted to gentamicin, its active form, by the enzyme diacetyl reductase. Gentamicin C1a pentaacetate has minimal toxicity and can be used for the treatment of infections caused by gram-positive species. This drug has been shown to be effective against bowel disease and infectious diseases. Gentamicin C1a pentaacetate is enzymatically inactivated by the wild-type strain of Escherichia coli and other gram-negative bacteria. The matrix effect may affect the pharmacokinetics of this drug, which can be studied using an analytical method.
Proprietà chimiche
Richiesta tecnica su: 3D-AG16458 Gentamicin C1a pentaacetate
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
